PDT Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-235,815
Closed -$15.1M 545
2018
Q4
$15.1M Buy
235,815
+37,741
+19% +$2.79M 0.84% 23
2018
Q3
$17.7M Sell
198,074
-22,399
-10% -$1.98M 0.74% 36
2018
Q2
$17.5M Buy
220,473
+28,686
+15% +$2.38M 0.66% 38
2018
Q1
$17.1M Buy
191,787
+3,731
+2% +$358K 0.58% 49
2017
Q4
$19.6M Buy
188,056
+121,135
+181% +$13.7M 0.57% 51
2017
Q3
$9.76M Sell
66,921
-7,835
-10% -$1.07M 0.32% 110
2017
Q2
$9.71M Buy
74,756
+19,082
+34% +$2.34M 0.39% 86
2017
Q1
$6.93M Buy
55,674
+7,918
+17% +$948K 0.36% 111
2016
Q4
$5.53M Sell
47,756
-44,100
-48% -$4.91M 0.36% 117
2016
Q3
$9.6M Buy
91,856
+24,300
+36% +$2.63M 0.56% 44
2016
Q2
$6.66M Buy
67,556
+21,700
+47% +$2.24M 0.53% 85
2016
Q1
$4.59M Buy
45,856
+15,454
+51% +$1.59M 0.29% 154
2015
Q4
$3.64M Buy
30,402
+11,246
+59% +$1.3M 0.5% 65
2015
Q3
$2.07M Sell
19,156
-62,150
-76% -$7.71M 0.05% 428
2015
Q2
$9.41M Sell
81,306
-112,986
-58% -$12.9M 0.25% 85
2015
Q1
$22.4M Buy
194,292
+183,836
+1,758% +$22M 0.56% 21
2014
Q4
$1.17M Sell
10,456
-60,878
-85% -$6.42M 0.11% 206
2014
Q3
$6.76M Buy
71,334
+64,478
+940% +$5.82M 0.17% 149
2014
Q2
$589K Sell
6,856
-389,954
-98% -$29.7M 0.02% 908
2014
Q1
$27.7M Buy
396,810
+389,954
+5,688% +$30.9M 0.67% 12
2013
Q4
$579K Sell
6,856
-18,574
-73% -$1.47M 0.07% 359
2013
Q3
$1.96M Sell
25,430
-367,982
-94% -$25.8M 0.05% 503
2013
Q2
$23M Buy
+393,412
New +$23.7M 0.56% 13

Other funds holding CELG

PDT Partners's CELG Position: Q1 2019 in Review

PDT Partners sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 235,815 shares — an estimated $15.1M sold.

PDT Partners first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $27.7M in Q1 2014. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • PDT Partners reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • PDT Partners sold 235,815 Celgene Corp shares in Q1 2019, an estimated $15.1M.
  • PDT Partners first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
  • PDT Partners's Celgene Corp position peaked at $27.7M in Q1 2014.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on PDT Partners's 13F filing for Q1 2019, filed 15 May 2019.